Your browser doesn't support javascript.
loading
Evaluation of short-term (16-week) effectiveness and safety of guselkumab in patients with psoriasis: A prospective real-life study on the Chinese population.
Zhuang, Jia-Yi; Li, Jin-Sheng; Zhong, Yuan-Qiu; Zhang, Fang-Fei; Li, Xin-Ze; Su, Hang; Zhang, Ze-Qiao; Wang, Xiao-Hua; Chen, Yong-Feng.
  • Zhuang JY; Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
  • Li JS; Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
  • Zhong YQ; Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
  • Zhang FF; Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
  • Li XZ; Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
  • Su H; Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
  • Zhang ZQ; Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
  • Wang XH; Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
  • Chen YF; Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.
Dermatol Ther ; 34(5): e15054, 2021 09.
Article en En | MEDLINE | ID: mdl-34228392

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article